Guidelines for randomised controlled trials investigating Chinese herbal medicine
Open Access
- 10 April 2012
- journal article
- review article
- Published by Elsevier BV in Journal of Ethnopharmacology
- Vol. 140 (3), 550-554
- https://doi.org/10.1016/j.jep.2011.12.017
Abstract
No abstract availableKeywords
Funding Information
- GP-TCM project
- European Commission
- Rufford Maurice Laing Foundation
This publication has 33 references indexed in Scilit:
- A traditional Chinese medicine versus Western combination therapy in the treatment of rheumatoid arthritis: two-stage study protocol for a randomized controlled trialTrials, 2011
- Acupuncture: filling the effectiveness gaps in Western medicine?British Journal of General Practice, 2011
- Systems Biology Guided by Chinese Medicine Reveals New Markers for Sub-Typing Rheumatoid Arthritis PatientsJCR: Journal of Clinical Rheumatology, 2009
- Developing and evaluating complex interventions: the new Medical Research Council guidanceBMJ, 2008
- Mechanisms of acquired resistance to endocrine therapy in hormone-dependent breast cancer cellsThe Journal of Steroid Biochemistry and Molecular Biology, 2007
- A phase II, randomized, blinded study of the farnesyltransferase inhibitor tipifarnib combined with letrozole in the treatment of advanced breast cancer after antiestrogen therapyBreast Cancer Research and Treatment, 2007
- The farnesyltransferase inhibitor R115777 (tipifarnib) in combination with tamoxifen acts synergistically to inhibit MCF-7 breast cancer cell proliferation and cell cycle progressionin vitroandin vivoMolecular Cancer Therapeutics, 2007
- Endocrine treatment options for advanced breast cancer – the role of fulvestrantEuropean Journal of Cancer, 2005
- Treatment of Breast CancerThe New England Journal of Medicine, 1998
- Endocrine therapy for advanced breast cancer: A reviewBreast Cancer Research and Treatment, 1992